Live feed08:00:00·820dPRReleasevia QuantisnowEyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular SurgeryByQuantisnow·Wall Street's wire, on your screen.EYEN· Eyenovia Inc.Health Care
